21 min
GLP1s and Bariatric Surgery with Dr. Dan Azagury ScrubCast
-
- Science
With the advent of GLP1s like Ozempic, aren’t Bariatric Surgeons out of a job?
We take a deep dive into obesity treatments with Dr. Dan Azagury, an Associate Professor in the Division of General Surgery and Chief of Minimally Invasive and Bariatric Surgery at Stanford University's Department of Surgery. We discuss topics such as how GLP1s were discovered and the benefits and risks of GLP-1 agonists. We also touch on the importance of holistic treatment for obesity and how medication and surgery are just two of the mechanisms for weight loss in their arsenal.
To close out the show, Dr. Azagury shares his admiration for Dr. Claude LeCoultre, who was Head of the Department of Pediatric Surgery at the University of Geneva from 1991 to 2004, and—of course—the best advice he’s received in 10 words or less.
You can learn more about Stanford Medical Weight Loss program here: https://stanfordhealthcare.org/medical-clinics/bariatric-surgery/medical-weight-loss-program.html
With the advent of GLP1s like Ozempic, aren’t Bariatric Surgeons out of a job?
We take a deep dive into obesity treatments with Dr. Dan Azagury, an Associate Professor in the Division of General Surgery and Chief of Minimally Invasive and Bariatric Surgery at Stanford University's Department of Surgery. We discuss topics such as how GLP1s were discovered and the benefits and risks of GLP-1 agonists. We also touch on the importance of holistic treatment for obesity and how medication and surgery are just two of the mechanisms for weight loss in their arsenal.
To close out the show, Dr. Azagury shares his admiration for Dr. Claude LeCoultre, who was Head of the Department of Pediatric Surgery at the University of Geneva from 1991 to 2004, and—of course—the best advice he’s received in 10 words or less.
You can learn more about Stanford Medical Weight Loss program here: https://stanfordhealthcare.org/medical-clinics/bariatric-surgery/medical-weight-loss-program.html
21 min